Sponsors sent nearly 4,500 ANDAs and the US Food and Drug Administration approved nearly 3,900 throughout the last five-year generic drug user fee cycle.
Agency data suggests a mostly steady volume of ANDA approvals and submissions during the program cycle, save for fiscal year...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?